StromaCare scientific Team has developed a deep expertise in identifying and understanding tumoral stroma components playing a key role in cancer, as demonstrated by several publications in major international scientific reviews.
StromaCare’s ambition is to develop innovative products in immuno-oncology to :
- Address specifically stromal components promoting tumor growth, immune escape and metastasis
- Modulate the stroma structure to enhance delivery of therapeutic agents at the core of the tumor and facilitate tumor resection surgery.